Clinical Trials Sponsored by Biolight AB

Total 1003 results

AB Biotics, SA
University of Extremadura

Completed

Combination of AB-LIFE Probiotic Plus Monacolin K to Reduce Blood Cholesterol

Hypercholesterolemia
Redwood Pharma AB
Cross Research S.A.

Completed

Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome

Dry Eye Syndromes

Austria, Germany, Hungary
Universitaire Ziekenhuizen KU Leuven
BioGaia AB

Completed

The Use of a Probiotic Lozenge in the Treatment of Residual Pockets After Classical Non-surgical Therapy

Periodontitis

Belgium
Case Western Reserve University
BioGaia AB

Completed

Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile

Antibiotic-associated Diarrhea | Clostridium Difficile

United States
Caroline Scott

Completed

Removal of Bacterial Spores in Adults on Skin

General Skin Cleansing

United States
Hemcheck Sweden AB
Landstinget i Värmland

Completed

Clinical Study of a Novel Hemolysis Point of Care Test at an Emergency Department.

Hemolysis | Blood Specimen Collection

Sweden
Newron Sweden AB
Quintiles, Inc.; Medtronic

Completed

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Parkinson's Disease

Sweden
Modus Therapeutics AB
University of Oxford

Terminated

Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria

Malaria, Falciparum

Thailand
Swedish Herbal Institute AB
Tbilisi State Medical University; Phytomed AB; National Family Medicine Training...

Completed

Efficacy of Adaptogens in Patients With Long COVID-19

Covid19

Georgia
Boston VA Research Institute, Inc.
VA Boston Healthcare System; Vielight Inc.

Recruiting

Photobiomodulation to Improve Cognition in TBI, With fMRI

Cognitive Dysfunction | Traumatic Brain Injury | Closed Head Injury

United States
M.D. Anderson Cancer Center
Active Biotech AB

Not yet recruiting

Open Label Phase 2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-Essential Thrombocytosis Myelofibrosis

United States
Suturion AB
Cross Research S.A.; Helsingborgs Hospital

Recruiting

Clinical Performance and Safety of Suture-TOOL

Wound Infection | Incisional Hernia | Laparotomy | Closure Technique

Sweden
PepTonic Medical AB
StatCons; Karolinska Trial Alliance

Recruiting

Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis

Vaginal Candidiasis | Candidal Vulvovaginitis | Vulvovaginal Candidiasis

Sweden
BioInvent International AB
Merck Sharp & Dohme LLC

Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Advanced Malignancies

United Kingdom, Denmark, Hungary, Russian Federation
Calliditas Therapeutics Suisse SA

Active, not recruiting

A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness (TRANSFORM)

Primary Biliary Cholangitis | Liver Stiffness

United States, Spain, France, Australia, Israel, Canada, Switzerland, Italy, New Zealand, Germany, Poland, Greece, United Kingdom, Belgium, Austria, Czechia, Hungary, Sweden
EpiEndo Pharmaceuticals
CTC Clinical Trial Consultants AB

Completed

Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin

COPD | Chronic Obstructive Pulmonary Disease Exacerbation

Sweden
Atrogi AB
Key2Compliance; CRS Clinical Research Services

Completed

First-in-human Single and Multiple Dose Trial of ATR-258

Type 2 Diabetes Mellitus

Germany
Atos Medical AB
The Netherlands Cancer Institute

Completed

Clinical Feasibility of a New Voice Prosthesis

Laryngectomy

Netherlands
Atos Medical AB
The Netherlands Cancer Institute

Completed

Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis

Total Laryngectomy

Netherlands
Roswell Park Cancer Institute
Active Biotech AB

Completed

Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Metastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate Cancer

United States
Galderma R&D
Pharma Consulting Group AB

Completed

Treatment of Pectus Excavatum Deformity Using Macrolane Filler

Pectus Excavatum Deformity

France, Sweden
Coegin Pharma AB
Bispebjerg Hospital; Studies&Me

Active, not recruiting

Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK (COAKS)

Actinic Keratoses

Denmark
Molnlycke Health Care AB
BioScience Laboratories, Inc.

Completed

Evaluation of the Residual Antimicrobial Efficacy of One Test Material Based on a Modification of ASTM E1115-11 Test Method

Hand Hygiene

United States
Gabather AB
Smerud Medical Research International AS

Completed

Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers (GAB-001)

Safety and Tolerability

Finland
Hansa Biopharma AB
University College London Hospitals

Terminated

IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients

Purpura, Thrombotic Thrombocytopenic

United Kingdom
Sahlgrenska University Hospital, Sweden
Calmino group AB

Completed

Aloe Vera in Irritable Bowel Syndrome

Irritable Bowel Syndrome

Sweden
Atos Medical AB
The Netherlands Cancer Institute

Completed

Long Term Use of the Provox Vega 22.5

Total Laryngectomy

Netherlands
Newron Sweden AB
Medtronic; ICON Clinical Research

Completed

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Belgium
Atos Medical AB
The Netherlands Cancer Institute

Completed

Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy (N08HME)

Total Laryngectomy

Netherlands
Kringle Pharma Europe AB
Kringle Pharma, Inc.

Unknown

Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers

Chronic Venous Leg Ulcers

Norway, Sweden
STB INN AB
Region Halland; Scandinavian CRO

Recruiting

Safety & Feasibility of PERIsign System in Demonstrating Involuntary Muscle Defense as a Sign of Peritonitis in Subjects With Appendicitis (PeriSaFe01)

Abdominal Pain | Appendicitis | Peritonitis | Appendicitis Acute

Sweden
BioInvent International AB
Merck Sharp & Dohme LLC

Recruiting

BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

Hepatocellular Carcinoma | Non Small Cell Lung Cancer | Solid Tumors

Spain, Denmark, Poland, Sweden
KK Women's and Children's Hospital
Inerventions AB

Recruiting

Can Transcutaneous Electrical Stimulation Garment Improve Gait in Children With Cerebral Palsy?

Cerebral Palsy | Spasticity, Muscle

Singapore
Karolinska Institutet
Sanofi; XNK Therapeutics AB, Sweden

Recruiting

Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma

Multiple Myeloma

Sweden
BioInvent International AB
Merck Sharp & Dohme LLC

Recruiting

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors (KEYNOTE-A04)

Solid Tumor, Adult

United States, Sweden
Karolinska Institutet
Karolinska University Hospital; Tiohundra AB

Recruiting

Digital Prevention of Asthma (AsthmaTuner)

Asthma | Care Management, Patient

Sweden
Galecto Biotech AB
Syneos Health; bioRASI, LLC

Completed

A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF)

United States, Spain, Israel, France, United Kingdom, Russian Federation, Australia, Italy, Germany, Canada, Belgium, Georgia, Ireland, Poland, Ukraine
Cereno Scientific AB
Abbott; Worldwide Clinical Trials

Available

Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Sweden
Galderma R&D
Pharma Consulting Group AB

Withdrawn

Macrolane Prospective Survey

Females Recently Treated With Macrolane VRF in the Breasts

Sweden
Cedars-Sinai Medical Center
Hansa Biopharma AB

Completed

Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation

Renal Disease

United States
AB Biotics, SA
Hospital Clinic of Barcelona

Completed

Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression

Bipolar Disorder

Spain
University of Alberta
SCA Hygiene Products, AB

Completed

A Trial of effectIveness of a Smart Sensor for Continence Care: the ARCTICC Study (ARCTICC)

Urinary Incontinence

Canada
Cumbria Partnership NHS Foundation Trust
BrainCool AB

Completed

BrainCool-Migraine Intranasal Cooling Trial

Migraine

United Kingdom
Research in Real-Life Ltd
Aerocrine AB

Completed

The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms (NSRS)

Asthma

United Kingdom
Adenovir Pharma AB
TFS Trial Form Support

Completed

Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)

Viral Conjunctivitis

Germany, Poland, Sweden
Ab Medica Spa
Centre Hospitalier Universitaire Vaudois

Unknown

New Anastomotic Device for End to End Vascular Anastomosis in the Treatment of Peripheral Vascular Disease (VJ)

Peripheral Vascular Disease | Femoropopliteal Occlusive Disease | Femoral Occlusive Disease | Aortoiliac Atherosclerosis

Switzerland
Nanexa AB
Profil Institut für Stoffwechselforschung GmbH

Not yet recruiting

Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D

Type 2 Diabetes
UPM Biomedicals
CTC Clinical Trial Consultants AB

Recruiting

An Investigation of Performance and Safety of the Wound Dressing FibDex in Patients With Superficial Dermal Burns

Burns

Sweden
Cantargia AB
Spanish Breast Cancer Research Group

Recruiting

Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer. (TRIFOUR)

Triple Negative Breast Cancer

Spain
BioGaia AB
Atlantia Food Clinical Trials; ActivInsights

Recruiting

Validation of Active-Insights Device to Measure Crying Time

Infant Behavior

Ireland

Clinical Trials Sponsored by Biolight AB

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations